유한양행: insider trades · South Korea · DART (FSS) DART:company-bc1326 KR KR · DART (FSS) Mcap 6235.3Bn€ Healthcare
Discover the full directors' dealings record of 유한양행, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 유한양행 has published 27 public disclosures. Market capitalisation: €6,235.3bn. The latest transaction was disclosed on 11 May 2026 — Purchase. Among the most active insiders: 김열홍. Every trade is free.
Financial data FY ended December 2025 · cache
Analyst consensus
20 analysts 81000.00 € Target 136450.00 €(+64%) 180000.00 €
Income statement
Revenue 2186.64 Bn€
Gross profit 729.92 Bn€ 33% margin
Net income 194.08 Bn€ 8.9% margin
Valuation
PER (forward) 28.3x
Beta 0.46
Balance sheet & cash
Market cap 6235.33 Bn€
Total debt 339.67 Bn€
Free Cash Flow −38.51 Bn€
Debt / Equity 15%
Profitability & ownership
ROE 8.2%
ROA 2.1%
% insiders 23.9%
% institutions 18.3%
Last declaration on 11 May 2026
Declarations 27 total
Executives ● Purchase24 DART
€15,935 300 shares @ €53.118 0.0000% mcap 100.0% of flow
DART:20260511000027 · 7 May 2026
Ideal exit: 1 Feb 2027 (T+270) Executives ● Purchase7 DART
€195m 4,006,483 shares
DART:20260511000534 · 11 May 2026
Ideal exit: 5 Feb 2027 (T+270) Executives ● Purchase30 DART
€15,953 300 shares @ €53.1765 0.0000% mcap 27.3% of flow
DART:20260511000017 · 7 May 2026
Ideal exit: 1 Feb 2027 (T+270) Executives ● Purchase31 DART
€5,323 100 shares @ €53.235 0.0000% mcap 40.2% of flow
DART:20260511000013 · 7 May 2026
Ideal exit: 1 Feb 2027 (T+270) Executives ● Purchase24 DART
€7,030 130 shares @ €54.0786 0.0000% mcap 100.0% of flow
DART:20260506000356 · 4 May 2026
Ideal exit: 29 Jan 2027 (T+270) Executives ● Purchase31 DART
€16,203 300 shares @ €54.0113 0.0000% mcap 37.8% of flow
DART:20260506000336 · 6 May 2026
Ideal exit: 31 Jan 2027 (T+270) Executives ● Purchase24 DART
€16,451 300 shares @ €54.8377 0.0000% mcap 100.0% of flow
DART:20260428000045 · 28 Apr 2026
Ideal exit: 23 Jan 2027 (T+270) Executives ● Purchase24 DART
€16,808 300 shares @ €56.0267 0.0000% mcap 100.0% of flow
DART:20260427000128 · 23 Apr 2026
Ideal exit: 18 Jan 2027 (T+270) Executives ● Purchase20 DART
€9,123 162 shares @ €56.3152 0.0000% mcap 37.4% of flow
DART:20260427000059 · 22 Apr 2026
Ideal exit: 17 Jan 2027 (T+270) Executives ● Purchase30 DART
€15,791 300 shares @ €52.6358 0.0000% mcap 27.0% of flow
DART:20260421000010 · 15 Apr 2026
Ideal exit: 10 Jan 2027 (T+270) Executives ● Purchase24 DART
€5,558 100 shares @ €55.581 0.0000% mcap 100.0% of flow
DART:20260420000027 · 17 Apr 2026
Ideal exit: 12 Jan 2027 (T+270) Executives ● Purchase24 DART
€17,452 314 shares @ €55.581 0.0000% mcap 100.0% of flow
DART:20260417000224 · 17 Apr 2026
Ideal exit: 12 Jan 2027 (T+270) Executives ● Purchase24 DART
€16,760 300 shares @ €55.8675 0.0000% mcap 100.0% of flow
DART:20260417000222 · 17 Apr 2026
Ideal exit: 12 Jan 2027 (T+270) Executives ● Purchase33 DART
€7,904 150 shares @ €52.6932 0.0000% mcap 59.8% of flow
DART:20260416000150 · 15 Apr 2026
Ideal exit: 10 Jan 2027 (T+270) Executives ● Purchase24 DART
€27,065 500 shares @ €54.129 0.0000% mcap 100.0% of flow
DART:20260414002426 · 14 Apr 2026
Ideal exit: 9 Jan 2027 (T+270) Executives ● Purchase24 DART
€10,892 200 shares @ €54.462 0.0000% mcap 100.0% of flow
DART:20260413001093 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase22 DART
€15,295 280 shares @ €54.6261 0.0000% mcap 62.6% of flow
DART:20260413001051 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase24 DART
€16,002 300 shares @ €53.3409 0.0000% mcap 100.0% of flow
DART:20260413001715 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) Executives ● Purchase24 DART
€16,547 300 shares @ €55.158 0.0000% mcap 100.0% of flow
DART:20260413001075 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase24 DART
€16,472 300 shares @ €54.9074 0.0000% mcap 100.0% of flow
DART:20260413001598 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase24 DART
€5,464 100 shares @ €54.636 0.0000% mcap 100.0% of flow
DART:20260413001472 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase24 DART
€12,735 240 shares @ €53.0615 0.0000% mcap 100.0% of flow
DART:20260410001952 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) Executives ● Purchase24 DART
€10,579 200 shares @ €52.896 0.0000% mcap 100.0% of flow
DART:20260410002137 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) Executives ● Purchase24 DART
€26,947 500 shares @ €53.8948 0.0000% mcap 100.0% of flow
DART:20260409000979 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) Executives ● Purchase24 DART
€10,753 200 shares @ €53.7631 0.0000% mcap 100.0% of flow
DART:20260409000331 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) 25 of 27 declarations
Load more (2 remaining) About 유한양행 Yuhan Corporation is a South Korean pharmaceutical company engaged in the research, development, and manufacturing of drugs. It is listed on the Korea Exchange, XKRX.
